These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5103296)

  • 41. [Therapy of advanced mammary carcinomas with high-dosed cytostatics].
    Boeckl O; Heitz N; Wasl H; Karrer K; Mannheimer E
    Munch Med Wochenschr; 1965 Oct; 107(43):2114-8. PubMed ID: 5899028
    [No Abstract]   [Full Text] [Related]  

  • 42. [Comparison of the effects of Cyclophosphamide, Cytembena and Ypenyl in the treatment of inoperable ovarian neoplasms].
    Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík J
    Cesk Gynekol; 1971 Sep; 36(7):431-3. PubMed ID: 5110665
    [No Abstract]   [Full Text] [Related]  

  • 43. [The effect of thiophosphamide on the glycogenetic and absorption-excretory function of the liver in patients with malignant tumors].
    Zel'vin BM; Trakhtenberg AKh
    Vopr Onkol; 1967; 13(12):9-14. PubMed ID: 4970403
    [No Abstract]   [Full Text] [Related]  

  • 44. [Our experience with chemotherapy of carcinoma of the ovary].
    Zara C; Gilardi G
    Arch Ostet Ginecol; 1970; 75(3):226-34. PubMed ID: 5516882
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of 126 cases of advanced ovarian carcinoma with cyclophosphamide.
    Beck RE; Boyes DA
    Can Med Assoc J; 1968 Mar; 98(11):539-41. PubMed ID: 5647240
    [No Abstract]   [Full Text] [Related]  

  • 46. Primary malignant melanoma in ovarian cystic teratoma.
    Vimla N; Kumar L; Thulkar S; Bal S; Dawar R
    Gynecol Oncol; 2001 Aug; 82(2):380-3. PubMed ID: 11531299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.
    Fortin D; Gendron C; Boudrias M; Garant MP
    Cancer; 2007 Feb; 109(4):751-60. PubMed ID: 17211866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Experience in postoperative long-term M.M.C. therapy of malignant ovarian tumor in a child].
    Fukuoka S; Naka T
    Iryo; 1970 Mar; 24(3):237-9. PubMed ID: 5421781
    [No Abstract]   [Full Text] [Related]  

  • 49. [Our experiences with the treatment of ovarian neoplasms with cytostatics].
    Kliment V; Stefanovic J; Kovalcíková J; Deák E; Ziak F; Manicová G; Rappová E
    Cesk Gynekol; 1971 Sep; 36(7):429-30. PubMed ID: 5110664
    [No Abstract]   [Full Text] [Related]  

  • 50. Bladder carcinoma associated with cyclophosphamide therapy for ovarian cancer occurring with a latency of 20 years.
    Volm T; Pfaff P; Gnann R; Kreienberg R
    Gynecol Oncol; 2001 Jul; 82(1):197-9. PubMed ID: 11426986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Ovarian metastasis of breast cancer: a case report. Role of cytoreductive surgery].
    Dubois N; Willems T; Myant N
    J Gynecol Obstet Biol Reprod (Paris); 2009 May; 38(3):242-5. PubMed ID: 19304411
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Report of experiences with ambulatory cytostatic chemotherapy in germinal testicular tumors and metastasizing renal carcinomas].
    Schulz R; Vogler H
    Z Urol Nephrol; 1981 Jan; 74(1):21-33. PubMed ID: 7195123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview.
    Hájek R; Vorlicek J; Slavik M
    Neoplasma; 1996; 43(3):141-54. PubMed ID: 8841500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cyclophosphamide--attack dose or continuous therapy].
    Müller U
    Zentralbl Gynakol; 1971 Oct; 93(40):1369-75. PubMed ID: 5126440
    [No Abstract]   [Full Text] [Related]  

  • 55. [ON CLINICAL TRIALS WITH THE CYTOSTATIC ENDOXAN].
    SCHULTE-BRINKMANN W; HOHN M
    Strahlentherapie; 1963 Aug; 121():625-39. PubMed ID: 14061230
    [No Abstract]   [Full Text] [Related]  

  • 56. [Correlation of histological findings and immediate therapeutical effect of cytostatic treatment in ovarian carcinoma].
    Popović ND; Nikolin L
    Med Pregl; 1976; 29(9-10):411-3. PubMed ID: 1004385
    [No Abstract]   [Full Text] [Related]  

  • 57. Chromosomes in malignant gynaecological effusions.
    Olinici CD; Galatir N; Lazarov P; Giurgiuman M
    Neoplasma; 1973; 20(3):311-24. PubMed ID: 4725517
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cyclophosphamide therapy in malignant diseases. Experience from a 10 year period in a medical department].
    Laursen ML
    Ugeskr Laeger; 1972 Feb; 134(6):269-73. PubMed ID: 5010245
    [No Abstract]   [Full Text] [Related]  

  • 59. Tentative clinical application of tetramezyl-mannitol (R52).
    Szentkláray J; Sellei C
    Neoplasma; 1967; 14(1):83-9. PubMed ID: 4166277
    [No Abstract]   [Full Text] [Related]  

  • 60. [The treatment of pain in patients with inoperable tumors, using xylocaine and cyclophosphamide of nitrogen mustard].
    Caminiti G
    Minerva Anestesiol; 1966 Jan; 32(1):57. PubMed ID: 4160106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.